Assessing the Effectiveness of Digital Wellness Modules on Perceived Quality of Life
Launched by YALE UNIVERSITY · Mar 30, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how digital wellness modules, which include mindfulness exercises and light to moderate physical activity, can improve people's quality of life and help with feelings of anxiety and depression. Participants will use a smartphone app to access these wellness activities and the study will track how these tools affect their motivation to change their health behaviors in the short-term, as well as their overall quality of life in the longer-term.
To be eligible for this study, participants must live in the United States and be between the ages of 65 and 74. However, certain health conditions may prevent someone from joining. For example, if a person has serious heart issues, joint pain, or certain mental health concerns, they may not be able to participate. Those who do take part can expect to engage with the wellness app and share how these activities impact their daily lives. This trial is currently recruiting participants, and it's a great opportunity for those looking to improve their well-being through guided digital support.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Resides in United States
- Exclusion Criteria:
- * Any individual who endorses any of the following criteria will be excluded from participation in this study:
- * Positive Health Screening Questions, as measured by the Health Screening Questionnaire (HSQ):
- • Pain, discomfort or pressure in the chest, difficulty breathing or shortness of breath, dizziness, fainting, or blackout, blood pressure with systolic greater than 140 or diastolic greater than 90, diagnosed or treated for any heart disease, heart murmur, chest pain (angina), palpitations (irregular beat), or heart attack, heart surgery, angioplasty, or a pacemaker, valve replacement, or heart transplant, resting pulse greater than 100 beats per minute, any arthritis, back trouble, hip /knee/joint /pain, or any other bone or joint condition, personal experience or doctor's advice of any other medical or physical reason that would prohibit the participant from doing light to moderate physical exercise, personal physician's recommendation against participating in light to moderate physical exercise because of asthma, diabetes, epilepsy or elevated cholesterol or a hernia.
- * Positive Psychiatric Disorders Screening Questions:
- • Positive screen for depression, excluding suicide (PHQ-8) cutoff score \> 6
- • Positive screen for panic (SMPD) cutoff score \> 2
- • Positive screen for generalized anxiety (GAD-7) cutoff score \> 10
- • Positive screen psychosis (PDSQ) via psychosis section, cutoff score \> 3
- • Positive screen mania via the Altman Self-Rating Mania Scale (ASRM) cutoff score \> 6
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New Haven, Connecticut, United States
Patients applied
Trial Officials
David Klemanski, Psy.D., MPH
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials